| Literature DB >> 27992470 |
Rodolfo Rossi1, Ramia Assaad2, Arianna Rebeschini1, Randa Hamadeh3.
Abstract
INTRODUCTION: With the high proportion of refugee population throughout Lebanon and continuous population movement, it is sensible to believe that, in particular vulnerable areas, vaccination coverage may not be at an optimal level. Therefore, we assessed the vaccination coverage in children under 5 in a district of the Akkar governorate before and after a vaccination campaign. During the vaccination campaign, conducted in August 2015, 2,509 children were vaccinated.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27992470 PMCID: PMC5167265 DOI: 10.1371/journal.pone.0168145
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Percentage distribution of children aged 12–59 months by selected background characteristics
| Variable | 1st survey | 2nd survey | Difference 1 vs 2 survey (95%CI of the difference) | P-value | ||
|---|---|---|---|---|---|---|
| N | % (95%CI) | N | % (95%CI) | |||
| 0.492 | ||||||
| Male | 112 | 53.3 (46.5; 60.1) | 118 | 56.2 (49.4; 63.0) | ||
| Female | 98 | 46.7 (39.9; 53.5) | 92 | 43.8 (37.0; 50.6) | -3.33% (-6.18; 12.84) | |
| 0.373 | ||||||
| Lebanese | 127 | 60.5 (53.8; 67.1) | 118 | 56.2 (49.4; 63.0) | ||
| Syrian | 83 | 39.5 (32.9; 46.5) | 92 | 43.8 (37.0; 50.6) | +4.29% (-5.14; 13.71) | |
| 0.631 | ||||||
| House/apartment | 164 | 78.1 (71.9; 83.5) | 168 | 80.0 (74.5; 85.5) | ||
| ITS/CS/other | 46 | 21.9 (16.5; 28.1) | 42 | 20.0 (14.5; 25.5) | -1.90% (-5.88; 9.69) | |
| <0.001 | ||||||
| Yes | 137 | 65.2 (58.4; 71.7) | 161 | 76.7 (70.9; 82.4) | +11.43% (2.81; 20.04) | |
| No | 73 | 34.8 (28.3; 41.6) | 49 | 23.3 (17.6; 29.1) | ||
| 0.031 | ||||||
| 12–23 | 83 | 39.5 (32.9; 46.5) | 62 | 29.5 (23.3; 35.7) | ||
| 24–59 | 127 | 60.5 (53.8; 67.1) | 148 | 70.5 (64.3; 76.7) | +10.00% (0.96; 19.04) | |
This is the legend of Table 1
Frequencies are unweighted (N = 210), percentages and their 95%CI are weighted.
*P-value from χ2 Test for the difference in proportion between first and second survey
percentages of each vaccine dose coverage in general and separated by nationality at the first survey
| Vaccine dose | Overall | Lebanese | Syrian | |
|---|---|---|---|---|
| % (95%CI) | % (95%CI) | % (95%CI) | p-value | |
| 91.9 (88.2; 95.6) | 92.9 (88.5; 97.4) | 90.4 (84.0; 96.7) | 0.507 | |
| 84.3 (79.3; 89.2) | 85.8 (79.8; 91.9) | 81.9 (73.6; 90.2) | 0.445 | |
| 71.9 (65.8; 78.0) | 76.4 (69.0; 83.8) | 65.1 (54.8; 75.3) | 0.074 | |
| 48.2 (40.6; 55.8) | 54.5 (44.7; 64.2) | 38.8 (27.1; 50.5) | 0.047 | |
| 88.1 (83.7; 92.5) | 89.0 (83.6; 94.4) | 86.7 (79.5; 94.0) | 0.626 | |
| 81.0 (75.6; 86.3) | 80.3 (73.4; 87.2) | 81.9 (73.6; 90.2) | 0.771 | |
| 70.5 (64.3; 76.7) | 74.1 (66.4; 81.6) | 65.1 (54.8; 75.3) | 0.164 | |
| 44.0 (36.5; 51.6) | 47.5 (37.8; 57.3) | 38.8 (27.1; 50.5) | 0.265 | |
| 65.7 (59.2; 72.2) | 66.9 (58.7; 75.1) | 63.9 (53.5; 74.2) | 0.646 | |
| 31.5 (24.4; 38.6) | 35.6 (26.3; 45.0) | 25.4 (15.0; 35.8) | 0.161 |
This is the legend of Table 2
*P-value from χ2 Test for difference in proportion between Lebanese and Syrians
§ Children of all ages (12–59 months)
¶ Children aged from 19 months and older who should have received polio 4, Pentavalent 4 and MMR 2
percentages of each vaccine dose coverage in general and separated by nationality at the second survey
| Vaccine dose | Overall | Lebanese | Syrian | |
|---|---|---|---|---|
| % (95%CI) | % (95%CI) | % (95%CI) | p-value | |
| 98.1 (96.2; 99.9) | 97.5 (94.6; 99.9) | 98.9 (96.8; 99.9) | 0.444 | |
| 95.2 (92.3; 98.1) | 94.1 (91.0; 98.9) | 95.6 (91.5; 99.8) | 0.803 | |
| 90.0 (85.9; 94.1) | 88.1 (82.3; 94.0) | 92.4 (87.0; 97.8) | 0.308 | |
| 82.7 (77.1; 88.3) | 80.0 (72.0; 88.0) | 85.7 (78.2; 93.2) | 0.313 | |
| 95.7 (93.0; 98.5) | 94.1 (89.8; 98.3) | 97.8 (94.8; 99.9) | 0.182 | |
| 90.5 (86.5; 94.5) | 86.4 (80.3; 92.6) | 95.7 (91.5; 99.8) | 0.024 | |
| 85.2 (80.4; 90.1) | 82.2 (75.3; 89.1) | 89.1 (82.8; 95.5) | 0.160 | |
| 70.4 (63.6; 77.1) | 71.6 (62.5; 80.6) | 69.0 (59.2; 78.9) | 0.711 | |
| 89.0 (84.8; 93.3) | 87.3 (81.3; 93.3) | 91.3 (85.5; 97.1) | 0.355 | |
| 55.1 (47.7; 62.4) | 51.1 (41.0; 61.2) | 59.2 (49.0; 70.0) | 0.257 |
This is the legend of Table 3
*P-value from χ2 Test for difference in proportion between Lebanese and Syrians
§ Children of all ages (12–59 months)
¶ Children aged from 19 months and older who should have received polio 4, Pentavalent 4 and MMR 2
difference between first and second survey in percentages of each vaccine dose coverage in general, and separated by nationality
| Vaccine dose | Difference 2nd vs 1st survey | |||||
|---|---|---|---|---|---|---|
| Overall | p-value | Lebanese | p-value | Syrians | p-value | |
| Polio1 | +6.2 (2.1;10.3) | 0.004 | +4.5 (-0.7;9.8) | 0.100 | +8.6 (1.9;15.2) | 0.010 |
| Polio2 | +11.0 (5.2;16.7) | <0.001 | +9.1 (1.8;16.3) | 0.017 | +13.7 (4.5;23.0) | 0.004 |
| Polio3 | +17.8 (10.4;25.1) | <0.001 | +11.2 (1.8;20.5) | 0.022 | +27.3 (15.7;38.9) | <0.001 |
| Polio4 | +34.6 (25.2;43.9) | <0.001 | +25.8 (13.2;38.3) | <0.001 | +46.9 (33.0;60.8) | <0.001 |
| Penta1 | +7.6 (2.5;12.8) | 0.004 | +5.1 (-1.8;12.0) | 0.155 | +11.1 (3.2;19.0) | 0.005 |
| Penta2 | +9.5 (2.9;16.2) | 0.005 | +6.1 (-3.1;15.4) | 0.199 | +13.7 (4.5;23.0) | 0.004 |
| Penta3 | +14.8 (6.9;22.6) | <0.001 | +8.2 (-2.1;18.5) | 0.122 | +24.1 (12.0;36.1) | <0.001 |
| Penta4 | +26.3 (16.3;36.4) | <0.001 | +24.1 (10.7;37.4) | <0.001 | +30.2 (14.9;45.5) | <0.001 |
| MMR1 | +23.3 (15.6;31.0) | <0.001 | +20.4 (10.2;30.5) | <0.001 | +27.4 (15.6;39.3) | <0.001 |
| MMR2 | +23.5 (13.4;33.6) | <0.001 | +15.4 (1.7;29.2) | 0.030 | +34.2 (19.4;48.9) | <0.001 |
This is the legend of Table 4
§Difference in proportion of vaccinated children per each antigen dose between the first and second survey
*P-value from the χ2 test for difference in proportions
Percentage of fully vaccinated children aged 12–59 months for each vaccine and with a complete vaccination calendar, by selected background characteristics and overall at the pre-campaign survey
| % (95%CI) | p-value | % (95%CI) | p-value | % (95%CI) | p-value | % (95%CI) | p-value | |
|---|---|---|---|---|---|---|---|---|
| 0.057 | 0.093 | 0.673 | 0.346 | |||||
| Male | 58.0 (48.9; 67.2) | 54.5 (45.2; 63.7) | 37.5 (28.5; 46.5) | 35.7 (26.8; 44.6) | ||||
| Female | 44.9 (35.1; 54.7) | 42.9 (33.1; 52.7) | 34.7 (25.3; 44.1) | 29.6 (20.6; 38.6) | ||||
| 0.045 | 0.184 | 0.372 | 0.199 | |||||
| Lebanese | 57.5 (48.9; 66.1) | 52.8 (44.1; 61.4) | 38.6 (30.1; 47.0) | 36.2 (27.9; 44.6) | ||||
| Syrian | 43.4 (32.7; 54.0) | 43.4 (32.7; 54.0) | 32.5 (22.5; 42.6) | 27.7 (18.1; 37.3) | ||||
| 0.050 | 0.128 | 0.567 | 0.144 | |||||
| House/apartment | 55.5 (47.9; 63.1) | 51.8 (44.2; 59.5) | 37.2 (29.8; 44.6) | 35.4 (28.0; 42.7) | ||||
| ITS/CS/other | 39.1 (25.0; 53.2) | 39.1 (25.0; 53.2) | 32.6 (19.1; 46.2) | 23.9 (11.6; 36.2) | ||||
| 0.320 | 0.217 | 0.004 | 0.008 | |||||
| El Bire | 57.1 (44.9; 69.4) | 55.6 (43.3; 67.8) | 50.8 (38.4; 63.1) | 46.0 (33.7; 58.3) | ||||
| Elsewhere | 49.7 (41.6; 57.7) | 46.3 (38.2; 54.3) | 29.9 (22.5; 37.3) | 27.2 (20.0; 34.4) | ||||
| 0.156 | 0.024 | 0.102 | 0.357 | |||||
| Yes | 55.5 (47.2; 63.8) | 54.7 (46.4; 63.1) | 40.1 (31.9; 48.4) | 35.0 (27.0; 43.0) | ||||
| No | 45.2 (33.8; 56.6) | 38.4 (27.2; 49.5) | 28.8 (18.4; 39.2) | 28.8 (18.4; 39.2) | ||||
| 0.557 | 0.935 | 0.564 | 0.827 | |||||
| 12–23 | 49.4 (38.6; 60.2) | 49.4 (38.6; 60.2) | 38.6 (28.1; 49.0) | 33.7 (23.6; 43.9) | ||||
| 24–59 | 53.5 (44.9; 62.2) | 48.8 (40.1; 57.5) | 34.6 (26.4; 42.9) | 32.3 (24.2; 40.4) | ||||
| 51.9 (44.9; 58.8) | — | 49.0 (42.1; 56.0) | — | 36.2 (29.7; 43.1) | — | 32.9 (26.5; 39.7) | — | |
This is the legend of Table 5
*P-value from the χ2 Test for difference in percentage
#El Bire is the only village in all Middle Dreib with a PHC public service
§To be fully vaccinated, a child needs to have received full course of Polio, Pentavalent and MMR according to his/her age.
¶Diphtheria, Pertussis, Tetanus, Haemo-Influenza B and Hepatitis B
¥Measles, Mumps, Rubella
ITS: Informal Tent Settlement
CS: Collective Shelter
Percentage of fully vaccinated children aged 12–59 months for each vaccine and with a complete vaccination calendar, by selected background characteristics and overall at the post-campaign survey
| % (95%CI) | p-value | % (95%CI) | p-value | % (95%CI) | p-value | % (95%CI) | p-value | |
|---|---|---|---|---|---|---|---|---|
| 0.331 | 0.505 | 0.380 | 0.888 | |||||
| Male | 86.4 (80.3; 92.6) | 73.7 (65.8; 81.7) | 63.6 (54.8; 72.2) | 54.2 (45.2; 63.2) | ||||
| Female | 81.5 (73.6; 89.5) | 69.6 (60.2; 79.0) | 57.6 (47.5; 67.7) | 53.3 (43.1; 63.5) | ||||
| 0.578 | 0.505 | 0.792 | 0.675 | |||||
| Lebanese | 83.1 (76.3; 89.8) | 73.7 (65.8; 81.7) | 60.2 (51.3; 69.0) | 55.1 (46.1; 64.1) | ||||
| Syrian | 85.7 (78.8; 93.0) | 69.6 (60.2; 79.0) | 62.0 (52.0; 71.9) | 52.2 (42.2; 62.4) | ||||
| 0.107 | 0.002 | 0.203 | 0.022 | |||||
| House/apartment | 86.3 (81.1; 91.6) | 76.8 (70.4; 83.2) | 63.1 (55.8; 70.4) | 57.7 (50.3; 65.2) | ||||
| ITS/CS/other | 76.2 (63.3; 89.1) | 52.4 (37.3; 67.5) | 52.4 (37.3; 67.5) | 38.1 (23.4; 52.8) | ||||
| 0.043 | 0.056 | 0.019 | 0.032 | |||||
| El Bire | 92.1 (85.4; 98.7) | 81.0 (71.3; 90.6) | 73.0 (62.1; 84.0) | 60.1 (53.3; 76.9) | ||||
| Elsewhere | 81.0 (74.6; 87.3) | 68.0 (60.5; 75.6) | 55.8 (47.8; 63.8) | 49.0 (40.9; 57.1) | ||||
| 0.560 | 0.124 | 0.338 | 0.904 | |||||
| Yes | 85.1 (79.6; 90.6) | 74.5 (67.8; 81.3) | 62.7 (55.3; 70.2) | 54.0 (46.3; 61.7) | ||||
| No | 81.6 (70.8; 92.5) | 63.3 (49.8; 76.8) | 55.1 (41.2; 69.0) | 53.1 (39.1; 67.0) | ||||
| 0.915 | 0.137 | 0.025 | 0.020 | |||||
| 12–23 | 83.9 (74.7; 93.0) | 79.0 (68.9; 89.2) | 72.6 (61.5; 83.7) | 66.1 (54.3; 77.9) | ||||
| 24–59 | 84.5 (78.6; 90.3) | 68.9 (61.5; 76.4) | 56.1 (48.1; 64.1) | 48.6 (40.6; 56.7) | ||||
| 84.3 (79.3; 89.2) | — | 71.9 (65.8; 78.0) | — | 61.0 (54.3; 67.6) | — | 53.8 (47.0; 60.6) | — | |
This is the legend of Table 6
*P-value from the χ2 Test for difference in percentage
#El Bire is the only village in all Middle Dreib with a PHC public service
§To be fully vaccinated, a child needs to have received full course of Polio, Pentavalent and MMR according to his/her age.
¶Diphtheria, Pertussis, Tetanus, Haemo-Influenza B and Hepatitis B
¥Measles, Mumps, Rubella
ITS: Informal Tent Settlement
CS: Collective Shelter
Change between pre- and post-campaign in percentage of fully vaccinated children aged 12–59 months for each vaccine and with a complete vaccination calendar, by selected background characteristics and overall
| Polio | Pentavalent | MMR | Fully vaccinated | |||||
|---|---|---|---|---|---|---|---|---|
| Characteristic | Diff% (95%CI) | p-value | Diff% (95%CI) | p-value | Diff% (95%CI) | p-value | Diff% (95%CI) | p-value |
| Male | +28.5 (17.5;39.5) | <0.001 | +19.5 (7.4;31.6) | 0.002 | +26.4 (13.9;38.8) | <0.001 | +18.9 (6.3;31.5) | 0.004 |
| Female | +36.4 (23.7;49.1) | <0.001 | +26.4 (12.7;40.0) | <0.001 | +22.4 (8.6; 36.3) | 0.002 | +23.2 (9.5;36.8) | 0.001 |
| Lebanese | +25.6 (14.6;36.5) | <0.001 | +21.0 (9.2;32.7) | <0.001 | +21.6 (9.4;33.8) | <0.001 | +18.9 (6.6;31.1) | 0.003 |
| Syrian | +42.5 (29.7;55.3) | <0.001 | +26.2 (12.0;40.4) | <0.001 | +29.4 (15.3;43.4) | <0.001 | +24.5 (10.4;38.5) | 0.001 |
| House/apart. | +30.8 (21.6;40.0) | <0.001 | +25.0 (15.0;34.9) | <0.001 | +25.9 (15.5;36.3) | <0.001 | +22.4 (11.9;32.8) | <0.001 |
| ITS/CS/Other | +37.1 (18.0;56.2) | <0.001 | +13.3 (-7.4;33.9) | 0.212 | +19.8 (-0.5;40.1) | 0.060 | +14.2 (-5.0;33.4) | 0.150 |
| 12–23 | +34.5 (20.3;48.6) | <0.001 | +29.6 (14.9;44.4) | <0.001 | +34.0 (18.8;49.3) | <0.001 | +32.4 (16.8;48.0) | <0.001 |
| 24–59 | +30.9 (20.5;41.4) | <0.001 | +20.1 (8.6;31.6) | <0.001 | +21.4 (9.9;32.9) | <0.001 | +16.4 (4.9;27.8) | 0.006 |
| +32.4 (24.0;40.7) | <0.001 | +22.9 (13.8;31.9) | <0.001 | +24.8 (15.5;34.0) | <0.001 | +21.0 (11.7;30.2) | <0.001 | |
This is the legend of Table 7
*P-value from the χ2 Test for difference in percentage
factors associated with being fully vaccinated at the second survey. Measure expressed as Odds Ratio (OR)
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| El Bire | 1.94 (1.05; 3.58) | 0.033 | 2.19 (1.03; 4.63) | 0.041 |
| Elsewhere | Ref | Ref | ||
| House/apartment | 2.22 (1.11; 4.44) | 0.024 | 3.17 (1.19; 8.44) | 0.021 |
| Tent/C. Shelter/other | Ref | Ref | ||
| 12–23 | 2.06 (1.11; 3.82) | 0.022 | 2.57 (1.22; 5.38) | 0.013 |
| 24–59 | Ref | Ref | ||
| Boys | 1.04 (0.60; 1.80) | 0.888 | 1.16 (0.61; 2.23) | 0.650 |
| Girls | Ref | Ref | ||
| Lebanese | Ref | Ref | ||
| Syrian | 0.89 (0.51; 1.54) | 0.675 | 1.15 (0.54; 2.47) | 0.718 |
| No | Ref | Ref | ||
| Yes | 0.92 (0.41; 2.06) | 0.835 | 1.61 (0.65; 4.00) | 0.305 |
| No | 1.59 (0.52; 4.85) | 0.413 | 2.02 (0.59; 6.92) | 0.263 |
| Yes | Ref | Ref |
This is the legend of Table 8
*P-value from Wald Test
#Adjusted for the other variables in the table
M.D.: Middle Dreib
Reported reasons for incomplete vaccination calendar (N = 115 at the 1st survey, N = 81 at the 2nd survey)
| Reported reason | 1st survey–n (%) | 2nd survey–n (%) |
|---|---|---|
| Information | 45 (39.1%) | 31 (38.3%) |
| Personal belief | 13 (11.3%) | 17 (21.0%) |
| Obstacles | 33 (28.7%) | 28 (34.6%) |
| Security | 1 (0.9%) | 0 (0.0%) |
| Other | 23 (20.0%) | 5 (6.2%) |
This is the legend of Table 9
* Information includes: awareness of need for immunisation and subsequent doses; awareness of where to get vaccinated
§ Personal belief also includes fear of side effects
#Obstacles includes: cost of service/transport, availability of vaccine, child too sick when at the clinic